Arch Biopartners Inc V.ARCH

Current Price $1.38 - Awaiting Human Data

[Riverfolk]

In my opinion there is zero premium built into this stock price, please find a list below of catalysts that have occured above todays price:

-Phase I Human trial completion
-Non-Brokered Financing at $1.50 share x 2
-Health Canada Approval of Phase II
-FDA Approval of Phase II
-Turkish Ministry of Health Approval of Phase II
-Expanded Canadian Hospital Participation in Phase II 
-Canadian Government Funding 6.7 Million for the Human Trial 
-Canadian Government Grant for Metablok
-Additional Patents for Drug Library

This market cap is cheap, but even cheaper to those that matter in the Pharma world..... This is trading at $1.11 US dollars

$62,000,000 US during Phase II for a new mechanism of action in inflammation... Lung,Liver,Kidney

[2019champs]

Good post. We are flying under the radar, which is good and bad. Good in a sense where we can still load up for very cheap. The news releases during the trials were very bullish. I think if it wasn't for a seller or two we would be in the mid $2 range. That also is very cheap considering this is a multi billion dollar market with little to no competition. I think alot of crappy canadian